10X Genomics (TXG) - News Mentions

Sign up to add (TXG) to your portfolio and access more historical data.

0 100%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 100%
Gilead Sciences
Gilead Sciences
GILD		 1 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), 10x Genomics (TXG) and Chugai Pharmaceutical Co (OtherCHGCF)
October 30
10X Genomics CEO Serge Saxonov Initiates Rule 10b5-1 Trading Plan Amid Strategic Financial Maneuvering
October 30
UBS Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $20.00
October 30
10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS
October 30
Q3 2024 10X Genomics Inc Earnings Call
October 29
10x Genomics Inc (TXG) Trading 4.91% Higher on Oct 30
October 29
Stifel Nicolaus Remains a Buy on 10x Genomics (TXG)
October 29
Bank of America Securities Sticks to Its Hold Rating for 10x Genomics (TXG)
October 29
10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
October 29
10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
October 29
10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates
October 29
10x Genomics, Inc. (TXG) Q3 2024 Earnings Call Transcript
October 29
Lower Instruments Sales to Hurt TXG Q3 Earnings, Prelim Sales Down
October 28
38,829 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Lecap Asset Management Ltd.
October 24
38,829 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Lecap Asset Management Ltd
October 24
10x Genomics (TXG) Upgraded to Strong Buy: Here's Why
October 23

Month over Month

Est. daily news mentions.

Sep 2024 1
Aug 2024 0
Jul 2024 1
Jun 2024 0

How often is 10X Genomics mentioned in the news?

10X Genomics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is 10X Genomics performing compared to its industry peers?

10X Genomics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of 10X Genomics in the last month?

There has been no significant change in the number of news mentions for 10X Genomics' compared to the last month.

Why is it important to track news mentions for 10X Genomics?

By monitoring mentions in the news for 10X Genomics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of 10X Genomics, ultimately improving their investment strategies.

Sign up and get more insights on 10X Genomics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact